Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Chondroplasty Market?

The market size of chondroplasty has experienced significant growth in the past years. There will be a rise from $13.77 billion in 2024 to $14.68 billion in 2025, showing a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this growth during the historic period include a surge in sports-related injuries, consumer inclination towards non-total joint replacement, advancements in postoperative care, enhanced training and proficiency of healthcare providers, and a rising incidence of joint disorders.

What Growth Rate Is Forecasted for the Chondroplasty Market by 2029?

Expectations are high for a robust growth in the chondroplasty market size in the upcoming years. By 2029, it is predicted to attain a value of $18.43 billion, with a compound annual growth rate (CAGR) of 5.9%. Factors contributing to this growth estimate for the forecast period include the incorporation of regenerative medicine, an emphasis on outpatient procedures, the introduction of innovative biomaterials, an increase in musculoskeletal disorders, and the growth of an elderly population. Predicted trends within this period encompass technology integration in rehabilitation, the application of arthroscopic techniques, advances in cartilage repair and regeneration, surgical tool innovation, and the integration of navigational systems.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13185&type=smp

Which Key Companies Are Shaping the Future of the Chondroplasty Market?

Major companies operating in the chondroplasty market report are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Osiris Therapeutics Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Medtronic Public Limited Company, Stryker Corporation, Teva Pharmaceutical Industries Ltd., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew PLC, Sigma-Aldrich Corporation, Arthrex Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., CONMED Corporation, Promega Corporation, Organogenesis Holdings Inc., Bioventus LLC, RTI Surgical Holdings Inc., Vericel Corporation, Geistlich Pharma AG, Ocugen Inc., MEDIPOST Co. Ltd., GPC Medical Ltd., Sklar Surgical Instruments, Isto Biologics, Nebula Inc., NuOrtho Surgical Inc., Medical Devices Business Services Inc.

Which Factors Are Driving Demand in the Chondroplasty Industry?

The chondroplasty market’s projected growth is largely due to an increased occurrence of joint-related health problems. These conditions, which impede joint functioning, can be a result of over-utilization or abrupt accidents, including sports injuries. Chondroplasty addresses these issues by mending the impaired joint cartilage. For example, The Lancet, a UK-based periodic data and book publisher, reported in August 2023, that the incidence of gout, a form of inflammatory arthritis that affects joints, escalated from 1.40 diagnoses per 1,000 adults in March 2021 to 1.44 diagnoses per 1,000 adults in March 2022 in the UK. Hence, the escalating prevalence of joint-related diseases contributes to the chondroplasty market’s growth trajectory. The impetus driving expansion in the chondroplasty market is the upswing in knee surgeries. These surgical methods treat various knee conditions, injuries, or disorders, and chondroplasty, in particular, is employed to repair and reshape the damaged joint cartilage, especially in the knee. For example, the National Library of Medicine, a US-based government library, confirmed in February 2022 that there were 2.4 million hip and knee surgeries performed across 1150 facilities, a 18.3% rise in total procedures relative to 2020. Furthermore, the same source indicated in January 2023 that total knee arthroplasty (TKA) is predicted to surge by 139% by 2040 and reach 469% by 2060. Thus, the uptrend in knee surgeries is fuelling the expansion of the chondroplasty market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13185&type=smp

How Is the Chondroplasty Market Segmented by Several Divisions?

The chondroplasty market covered in this report is segmented –

1) By Type: Radiofrequency Ablation Chondroplasty, Abrasion Chondroplasty, Atellar Chondroplasty, Meniscal Repair, Tissue Removal, Other Types

2) By Anatomy: Knee, Shoulder, Hip, Other Anatomies

3) By Equipment: Shavers, Radiofrequency Devices, Arthroscope, Other Equipments

4) By End Use: Hospitals, Orthopedic Clinics, Academic Research, Other End Uses

Subsegments:

1) By Radiofrequency Ablation Chondroplasty: High-Frequency Ablation, Low-Frequency Ablation

2) By Abrasion Chondroplasty: Mechanical Abrasion, Arthroscopic Abrasion

3) By Patellar Chondroplasty: Open Patellar Chondroplasty, Arthroscopic Patellar Chondroplasty

4) By Meniscal Repair: Suturing Techniques, Meniscal Allograft Transplantation

5) By Tissue Removal: Arthroscopic Debridement, Open Debridement

6) By Other Types: Microfracture Techniques, Osteochondral Autograft Transplantation

What are the Emerging Market Trends Driving the Growth of the Chondroplasty Industry?

Leading entities in the chondroplasty industry are focusing on the creation of autologous chondrocytes, which leverages the cells of the patients to aid in cartilage repair, thus lowering the chances of immune rejection and encouraging natural regeneration. These are cartilage cells that are generally taken from an area of the joint that doesn’t bear weight. To illustrate, Vericel Corporation, a biopharmaceutical establishment based in the US, secured FDA approval and started the commercial distribution of MACI Arthro (Matrix Autologous Chondrocyte Implantation) in August 2024. This marked a substantial improvement in the treatment of knee cartilage defects. MACI Arthro equips orthopedic surgeons to carry out the procedure through minor incisions by using specially designed tools, which is less intrusive compared to the conventional methods. This strategy is anticipated to augment patient recovery and diminish complications after surgery.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/chondroplasty-global-market-report

Which Regions Are Driving Growth in the Chondroplasty Market?

North America was the largest region in the chondroplasty market in 2024. The regions covered in the chondroplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13185

This Report Delivers Insight On:

1. How big is the chondroplasty market, and how is it changing globally?

2. Who are the major companies in the chondroplasty market, and how are they performing?

3. What are the key opportunities and risks in the chondroplasty market right now?

4. Which products or customer segments are growing the most in the chondroplasty market?

5. What factors are helping or slowing down the growth of the chondroplasty market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model